Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Authors
Publication date
Publisher
Oxford University Press
Doi
    View on PubMed

    Abstract

    Objective. To assess the efficacy of rituximab (RTX) in SSc

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 03/12/2019